# Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare

> **NCT01797796** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06305591
- **OTHER:** Capsaicin challenge
- **DRUG:** Placebo
- **OTHER:** Capsaicin challenge

## Key facts

- **NCT ID:** NCT01797796
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797796, "Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01797796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*